Charles Perkins Centre, School of Health Sciences, Faculty of Medicine and Health, the University of Sydney, Camperdown, Australia.
Centre for Active and Healthy Ageing, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
BMC Med. 2023 Mar 2;21(1):75. doi: 10.1186/s12916-023-02732-x.
The complexity of sleep hinders the formulation of sleep guidelines. Recent studies suggest that different unhealthy sleep characteristics jointly increase the risks for cardiovascular disease (CVD). This study aimed to estimate the differences in CVD-free life expectancy between people with different sleep profiles.
We included 308,683 middle-aged adults from the UK Biobank among whom 140,181 had primary care data linkage. We used an established composite sleep score comprising self-reported chronotype, duration, insomnia complaints, snoring, and daytime sleepiness to derive three sleep categories: poor, intermediate, and healthy. We also identified three clinical sleep disorders captured by primary care and inpatient records within 2 years before enrollment in the cohort: insomnia, sleep-related breathing disorders, and other sleep disorders. We estimated sex-specific CVD-free life expectancy with three-state Markov models conditioning on survival at age 40 across different sleep profiles and clinical disorders.
We observed a gradual loss in CVD-free life expectancy toward poor sleep such as, compared with healthy sleepers, poor sleepers lost 1.80 [95% CI 0.96-2.75] and 2.31 [1.46-3.29] CVD-free years in females and males, respectively, while intermediate sleepers lost 0.48 [0.41-0.55] and 0.55 [0.49-0.61] years. Among men, those with clinical insomnia or sleep-related breathing disorders lost CVD-free life by 3.84 [0.61-8.59] or 6.73 [5.31-8.48] years, respectively. Among women, sleep-related breathing disorders or other sleep disorders were associated with 7.32 [5.33-10.34] or 1.43 [0.20-3.29] years lost, respectively.
Both self-reported and doctor-diagnosed poor sleep are negatively associated with CVD-free life, especially pronounced in participants with sleep-related breathing disorders.
睡眠的复杂性阻碍了睡眠指南的制定。最近的研究表明,不同的不健康睡眠特征共同增加了心血管疾病(CVD)的风险。本研究旨在估计不同睡眠特征人群的无 CVD 预期寿命差异。
我们纳入了英国生物库(UK Biobank)中的 308683 名中年成年人,其中 140181 人有初级保健数据链接。我们使用了一种已建立的综合睡眠评分,包括自我报告的生物钟、睡眠时间、失眠抱怨、打鼾和白天嗜睡,来得出三种睡眠类别:差、中等和健康。我们还确定了在队列入组前 2 年内通过初级保健和住院记录记录的三种临床睡眠障碍:失眠、睡眠相关呼吸障碍和其他睡眠障碍。我们使用三状态马尔可夫模型,根据不同睡眠特征和临床障碍下 40 岁时的生存情况,估计了性别特异性无 CVD 预期寿命。
我们观察到较差的睡眠导致无 CVD 预期寿命逐渐丧失,例如,与健康睡眠者相比,较差睡眠者的女性和男性分别失去了 1.80 岁[95%CI 0.96-2.75]和 2.31 岁[1.46-3.29]的无 CVD 预期寿命,而中等睡眠者分别失去了 0.48 岁[0.41-0.55]和 0.55 岁[0.49-0.61]。在男性中,患有临床失眠或睡眠相关呼吸障碍的人分别失去了 3.84 岁[0.61-8.59]或 6.73 岁[5.31-8.48]的无 CVD 预期寿命。在女性中,睡眠相关呼吸障碍或其他睡眠障碍分别与失去 7.32 岁[5.33-10.34]或 1.43 岁[0.20-3.29]的无 CVD 预期寿命相关。
自我报告和医生诊断的较差睡眠都与无 CVD 预期寿命呈负相关,特别是与睡眠相关呼吸障碍相关的睡眠较差更为明显。